A Problem with the Evidence
Current best estimates are that only some 25 to 30 percent of us are capable of reading and understanding the content of the New York Times Science section.
Category: Thinking About Addiction
Across the Spectrum of Policy, Practice, Research & Reality.
Commentary and analysis about anything related to addiction, treatment, or recovery, all the way from prevention to building recovery-friendly communities.
Thinking About Addiction
Latest
Arc of the Pendulum
Instead, our habit has been to rush head first in one direction, then reverse and rush back the opposite way
Read More
Some Downward Progress
Many older folks turn to cannabis to self-medicate the pain and sleep problems that can plague old age. As they become dependent on cannabis, we could see the emergence of more health-related problems there.
Read More
Odds & Ends from Research
And according to the researchers, (SGB) seems to have a positive impact on other problems that co-occur with PTSD– anxiety, depression, alcohol consumption.
Read More
Mean Green
At this point in the US, there are allegedly a couple of hundred thousand people who would reasonably qualify as ketamine-addicted.
Read More
Good News on the Overdose Front
Some less good news: Law enforcement sees evidence of aggressive efforts by drug cartels to establish supply lines and operations within the US.
Read More
An MD takes on the DEA
Still, “pill mills” do continue to exist, if not in the numbers they once did. I suppose they could stage a comeback — the economics still work.
Read More
Another Country Tries Prohibition
…efforts to provide treatment for the many victims of rampant alcoholism have been relatively rare, largely volunteer efforts funded by donations rather than much in the way of government support.
Read More
More Bad Medicine
Seriously, how dumb, or perhaps desperate, would a medical professional have to be to undertake something like this?
Read More
Legal Cannabis: Success or Not?
…it’s an omen of bad times to come. Why? Because people in New Mexico’s cities are not buying enough pot.
Read More
The Bill Comes Due
ALD (alcohol-related liver disease) in the United States is projected to cost $355 billion in direct healthcare-related costs and $525 billion in lost labor and economic consumption.
Read More
The Power of Drug Company Marketing
…a number of years ago, the Institute of Medicine set forth guidelines intended to reduce the influence of advertising on how physicians prescribed medications… to date, relatively few physicians have actually adopted those guidelines.
Read More
Bongs for Sale, Cheap
…the goal, as one official described it, is to “discourage unlicensed cannabis activities and to help level the playing field for legitimate businesses paying their taxes.”
Read More